BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24915493)

  • 21. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.
    Ezquer F; Ezquer M; Contador D; Ricca M; Simon V; Conget P
    Stem Cells; 2012 Aug; 30(8):1664-74. PubMed ID: 22644660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and β-cell differentiation in streptozocin-induced diabetic mice.
    Ho JH; Tseng TC; Ma WH; Ong WK; Chen YF; Chen MH; Lin MW; Hong CY; Lee OK
    Cell Transplant; 2012; 21(5):997-1009. PubMed ID: 22004871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-Cell regeneration mediated by human bone marrow mesenchymal stem cells.
    Milanesi A; Lee JW; Li Z; Da Sacco S; Villani V; Cervantes V; Perin L; Yu JS
    PLoS One; 2012; 7(8):e42177. PubMed ID: 22879915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocyte growth factor is constitutively produced by donor-derived bone marrow cells and promotes regeneration of pancreatic beta-cells.
    Izumida Y; Aoki T; Yasuda D; Koizumi T; Suganuma C; Saito K; Murai N; Shimizu Y; Hayashi K; Odaira M; Kusano T; Kushima M; Kudano M
    Biochem Biophys Res Commun; 2005 Jul; 333(1):273-82. PubMed ID: 15950193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of stem cell differentiation in diabetic rats transplanted with bone marrow mesenchymal stem cells.
    Lin P; Chen L; Yang N; Sun Y; Xu YX
    Transplant Proc; 2009 Jun; 41(5):1891-3. PubMed ID: 19545751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxic Preconditioning Improves the Therapeutic Potential of Aging Bone Marrow Mesenchymal Stem Cells in Streptozotocin-Induced Type-1 Diabetic Mice.
    Waseem M; Khan I; Iqbal H; Eijaz S; Usman S; Ahmed N; Alam G; Salim A
    Cell Reprogram; 2016 Oct; 18(5):344-355. PubMed ID: 27500307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Hematopoietic Stem Cells in Inflammation of the Pancreas during Diabetes Mellitus.
    Dygai AM; Skurikhin EG; Pershina OV; Ermakova NN; Krupin VA; Ermolaeva LA; Stakheeva MN; Choinzonov EL; Goldberg VE; Reikhart DV; Ellinidi VN; Kravtsov VY
    Bull Exp Biol Med; 2016 Feb; 160(4):474-9. PubMed ID: 26906195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin expressed from endogenously active glucose-responsive EGR1 promoter in bone marrow mesenchymal stromal cells as diabetes therapy.
    Chen NK; Tan SY; Udolph G; Kon OL
    Gene Ther; 2010 May; 17(5):592-605. PubMed ID: 20182520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats.
    Xie Z; Hao H; Tong C; Cheng Y; Liu J; Pang Y; Si Y; Guo Y; Zang L; Mu Y; Han W
    Stem Cells; 2016 Mar; 34(3):627-39. PubMed ID: 26523620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice.
    Wang HS; Shyu JF; Shen WS; Hsu HC; Chi TC; Chen CP; Huang SW; Shyr YM; Tang KT; Chen TH
    Cell Transplant; 2011; 20(3):455-66. PubMed ID: 20719086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cells adopt beta-cell fate upon diabetic pancreatic microenvironment.
    Chang C; Wang X; Niu D; Zhang Z; Zhao H; Gong F
    Pancreas; 2009 Apr; 38(3):275-81. PubMed ID: 19066494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells into Insulin-Producing Cells: Evidence for Further Maturation In Vivo.
    Gabr MM; Zakaria MM; Refaie AF; Khater SM; Ashamallah SA; Ismail AM; El-Halawani SM; Ghoneim MA
    Biomed Res Int; 2015; 2015():575837. PubMed ID: 26064925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can Stem Cells Ameliorate the Pancreatic Damage Induced by Streptozotocin in Rats?
    El Barky AR; Ezz AAH; Alm-Eldeen AA; Hussein SA; Hafez YA; Mohamed TM
    Can J Diabetes; 2018 Feb; 42(1):61-70. PubMed ID: 28642056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow mesenchymal stromal cells rescue cardiac function in streptozotocin-induced diabetic rats.
    Monnerat-Cahli G; Trentin-Sonoda M; Guerra B; Manso G; Ferreira AC; Silva DL; Coutinho DC; Carneiro-Ramos MS; Rodrigues DC; Cabral-da-Silva MC; Goldenberg RC; Nascimento JH; Campos de Carvalho AC; Medei E
    Int J Cardiol; 2014 Feb; 171(2):199-208. PubMed ID: 24374203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow-derived cells.
    Nagaishi K; Ataka K; Echizen E; Arimura Y; Fujimiya M
    Hepatology; 2014 May; 59(5):1816-29. PubMed ID: 24375439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow-derived stem cells initiate pancreatic regeneration.
    Hess D; Li L; Martin M; Sakano S; Hill D; Strutt B; Thyssen S; Gray DA; Bhatia M
    Nat Biotechnol; 2003 Jul; 21(7):763-70. PubMed ID: 12819790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats.
    Najafi R; Sharifi AM
    Expert Opin Biol Ther; 2013 Jul; 13(7):959-72. PubMed ID: 23536977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased β-cell replication and β-cell mass regeneration in syngeneically transplanted rat islets overexpressing insulin-like growth factor II.
    Estil les E; Téllez N; Escoriza J; Montanya E
    Cell Transplant; 2012; 21(10):2119-29. PubMed ID: 22507193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperglycemia promotes vasculogenesis in choroidal neovascularization in diabetic mice by stimulating VEGF and SDF-1 expression in retinal pigment epithelial cells.
    Cai Y; Li X; Wang YS; Shi YY; Ye Z; Yang GD; Dou GR; Hou HY; Yang N; Cao XR; Lu ZF
    Exp Eye Res; 2014 Jun; 123():87-96. PubMed ID: 24780853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors.
    Bhonde RR; Sheshadri P; Sharma S; Kumar A
    Int J Biochem Cell Biol; 2014 Jan; 46():90-102. PubMed ID: 24275096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.